Last reviewed · How we verify
NCT04662307
An Intelligent Cardiopulmonary Rehabilitative System on Cardiopulmonary Fitness
NA trial testing Intelligent cardiopulmonary rehabilitation system (ICRS) in Lifestyle, Sedentary in 10 participants. Status unknown.
15 December 2022
Quick facts
| Lead sponsor | Taipei Medical University WanFang Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 15 December 2020 |
| Primary completion | 15 December 2022 |
| Estimated completion | 15 January 2023 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Intelligent cardiopulmonary rehabilitation system (ICRS)
Conditions studied
- Lifestyle, Sedentary — all drugs for Lifestyle, Sedentary →
Sponsor
Taipei Medical University WanFang Hospital
Who can join
Adults 20 to 75, any sex, with Lifestyle, Sedentary. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Contemporary cardiopulmonary rehabilitation programs often utilize cycling ergometer, involving one-on-one heart rate monitoring by physiotherapists to ensure that patients reach the target training intensity during training sessions. However, the process is frequently described as monotonous and boring, resulting in early fatigue of therapists and patients as well as poor compliance, leading to undertraining and suboptimal outcomes. This study aims to test the feasibility of the "Intelligent Cardiopulmonary Training System (ICRS)" and a novel indicator of measuring the adherence to training intensity. The ICRS was developed with the idea to provide machine-based supervision on the user's heart rate during training. It provides moderate-intensity continuous training with a cycling ergometer. This system automatically adjusts the paddling resistance according to the user's real-time heart rate, and helps to improve the user's adherence to pre-determined training intensity without trainer's watch. The automation of intensity adjustment has its potential for conditions in which supervision is not feasible.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04662307
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lifestyle, Sedentary
Currently open trials in the same condition.
- NCT04716322 — Health-Enhancing Adapted Physical Activity Program at "Mon Stade" · NA · recruiting
- NCT04173715 — Movement and Behaviours Measurement Study · recruiting
Other Taipei Medical University WanFang Hospital trials
Trials by the same sponsor.
- NCT07401017 — The Effects of Rosuvastatin on Running Training Adaptation and Safety · NA · not yet recruiting
- NCT07293442 — Pelvic Floor Muscle Exercise for Lower Urinary Tract Symptoms After Surgery for Benign Prostatic Hyperplasia. · NA · recruiting
- NCT07150182 — Shared Decision-Making for Families in Critical Dialysis Initiation · NA · not yet recruiting
- NCT06834425 — Efficacy of NSAID Peritendinous Injection for Acute Tendinitis · NA · active not recruiting
- NCT06862297 — Prospective Study Between Polysomnography (PSG) and Novel Ultrasonic Jaw Tracking Device in Patients with Sleep Apnea · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04662307 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Taipei Medical University WanFang Hospital
- Last refreshed: 11 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04662307.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing